Mindfulness-Based Cognitive Therapy in Advanced Prostate Cancer: A Randomized Controlled Trial

Suzanne K Chambers1, Stefano Occhipinti1, Elizabeth Foley1

  • 1Suzanne K. Chambers, Stefano Occhipinti, Melissa Legg, and David P. Smith, Griffith University, Gold Coast; Suzanne K. Chambers, Samantha Clutton, Melissa Legg, Cancer Council Queensland; Robert A. Gardiner, University of Queensland, Brisbane; Suzanne K. Chambers, University of Southern Queensland, Toowoomba, Queensland; Suzanne K. Chambers, Prostate Cancer Foundation of Australia; Suzanne K. Chambers, Stefano Occhipinti, Samantha Clutton, Melissa Legg, Martin Berry, Martin R. Stockler, Mark Frydenberg, Robert A. Gardiner, Ian D. Davis, and David P. Smith, Australian and New Zealand Urogenital and Prostate Cancer Trials Group; Elizabeth Foley, Mind Potential; Martin R. Stockler, and David P. Smith, University of Sydney; David P. Smith, Cancer Council New South Wales, Sydney; Martin Berry, Central Coast Cancer Centre, Gosford; Martin R. Stockler, Concord Repatriation General Hospital, Concord, New South Wales; Suzanne K. Chambers, Robert A. Gardiner, Edith Cowan University, Perth, Western Australia; Mark Frydenberg, Monash Health; Mark Frydenberg, Ian D. Davis, Monash University; Ian D. Davis, Eastern Health, Melbourne, Victoria, Australia; and Stephen J. Lepore, Temple University, Philadelphia, PA.

Summary

Mindfulness-based cognitive therapy (MBCT) did not significantly reduce distress in men with advanced prostate cancer (PC). Future research should explore interventions better suited to male patients.